IFITM1 and benign neoplasm: In our previous study, based on reverse transcription–polymerase chain reaction (RT-PCR)-based differential display analysis, we found that interferon-induced transmembrane protein 1 (IFITM1) was downregulated in MPNST tissues of patients with NF1 compared to that in benign tumor tissues [29].